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Abstract 
Objectives: To assess the baseline knowledge of fourth year student pharmacists on their ability to properly identify and categorize 
medication related problems (MRP) during their Advanced Pharmacy Practice Experience (APPE) in the ambulatory care setting, and 
to assess the efficacy of a written resource designed to educate and train users on identification and documentation of MRP’s and 
used for this purpose with participating students on their ambulatory care APPE.  
Methods: A pretest consisting of ten multiple-choice questions was administered electronically to fourth year student pharmacists 
(N=18) at the start of their ambulatory care APPE. The test was designed to assess both the students’ baseline knowledge regarding 
MRP’s, and their ability to identify a wide variety of medication-related problems. Students then received a written copy of The 
Medication Therapy Intervention & Safety Documentation Program training manual and were asked to read it in its entirety in the 
first week of their APPE. Finally, students were given a posttest survey (identical to the pretest) to complete to assess if their 
knowledge had increased from baseline. 
Results: The average score for the 18 students taking the baseline knowledge pre-test was 63.33%, indicating limited baseline 
knowledge regarding the identification and classification of MRP’s. In assessing the effectiveness of the written training document, 
the overall posttest results compared to pretest results did not indicate improvement in students’ knowledge or ability to properly 
identify and classify medication related problems (MRP) after reviewing the training manual. The average scores declined from 
63.33% on the pretest to 62.78% on the posttest, although this was not found to be statistically significant (p = 0.884). However, a 
statistically significant decline in students’ knowledge occurred on one specific question, which tested their ability to classify MRP’s (p 
= 0.029). 
Conclusions: Based on the results of the pre-test, students at our institution enter their APPE year with limited baseline knowledge of 
medication safety within the ambulatory care setting. Results from the posttest indicate potential ineffectiveness of a written 
document in providing effective education on MRP’s to students in the experiential setting. Education may be made more effective 
with a hands-on, active learning approach that overcomes the limitations of other passive forms of learning. 
 
Introduction 
In November 1999, the Institute of Medicine (IOM) released 
its landmark report, To Err is Human: Building a Safer Health 
System, which discussed the dire need to address medical 
errors within the United States healthcare system. The report 
estimated up to 98,000 deaths occur annually due to 
preventable medical errors.1 These unfortunate incidents in 
turn cost approximately $29 billion in both profits lost and 
augmented health care costs. 1 Since the release of the  
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report, there have been many other reports and research 
addressing the morbidity and mortality rates of patients in 
the United States due to medication errors. 2,3 However, it has 
only been within the last decade that the focus on patient 
safety has begun to shift from almost exclusively inpatient 
care to include the outpatient arena. The Agency for the 
Healthcare Research and Quality (AHRQ), specifically 
addressed this issue stating, “medical error and injury are 
substantial in ambulatory care, but there has been little 
systematic research specifically aimed at patient safety 
questions in ambulatory care.” 4  
Of the 98,000 deaths that were estimated to occur annually 
by the IOM report, about 7,000 of them can be directly 
associated to a medication related problem (MRP) such as 
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medication errors, adverse drug events, or adverse drug 
reactions. 1 The National Coordinating Council for Medication 
Error Reporting and Prevention (NCC MERP) defines a 
medication error as any preventable event that may cause, or 
inevitably lead to, harm to the patient. 5 Only an estimated 
1% of medication errors cause patient harm, as some either 
do not reach the patient, or reach the patient but don’t have 
a clinical impact. 6 However, a medication error could result in 
either an adverse drug event (ADE), which is described as an 
injury from the use of a drug (at normal doses or from an 
overdose), or an adverse drug reaction (ADR), characterized 
as an unintended response to a drug at normal doses or 
during proper use. 6 Not all ADE’s and ADR’s are related to 
medication errors; however, it is estimated that 25% of all 
ADE’s and ADR’s can be directly linked to a medication error, 
meaning that for every four patients harmed by a medication, 
one of the incidents could have been prevented.6  
Research has shown that MRP’s can be reduced through the 
implementation of medication safety programs.7 In order to 
ensure successful implementation of these programs, it is 
imperative that pharmacists are involved.8-11 The American 
Society of Health-System Pharmacists (ASHP) endorses this 
concept, stating that “medication safety is the fundamental 
responsibility of all members of pharmacy.”10 ASHP goes on 
to say that, “because of their training, abilities, and 
knowledge of the medication-use process, pharmacists are 
uniquely qualified to fill the roles and meet the 
responsibilities as a pertinent team member regarding 
medication safety in health systems.”10 The Institute for Safe 
Medication Practices (ISMP) also supports the utilization of 
pharmacists in relation to medication safety. In their two part 
series entitled Medication Errors: A Year in Review, they 
state, “the prevention of medication errors is an essential 
component of pharmaceutical care and must be a core 
mission of every pharmacy.”11  
Understanding the importance of medication safety, ASHP 
has encouraged schools of pharmacy and residency programs 
throughout the nation to incorporate an increased amount of 
medication safety training in their respective programs.12 
Furthermore, the Accreditation Council for Pharmacy 
Education (ACPE) suggested schools of pharmacy should 
consider integrating more patient safety training and 
increasing their advancements on measuring, reporting, and 
improving the quality of pharmacy practice to reduce the 
medication-related problems.13 In their 2011 update, the 
Accreditation Council for Pharmacy Education (ACPE) 
identified several factors for this focus, which included 
reports from the Institute of Medicine (IOM) that described 
the changes needed in the United States healthcare system.13 
The IOM noted the following five competencies that all 
healthcare professionals should attain during their education 
to improve medication safety and patient outcomes: provide 
patient-centered care, work in interprofessional teams, 
employ evidence-based practice, apply quality improvement, 
and utilize informatics.14   
Existing pharmacy education literature indicates that the 
education students receive on medication safety typically 
exists in the didactic classroom, without the incorporation of 
a skill-oriented environment such as a laboratory or 
inpatient/outpatient experience.15,16 There are, however, a 
few exceptions. One institution in particular, Purdue 
University, sought to create a laboratory setting experience in 
which students were involved in identifying medication 
errors.17 Specifically, students were introduced to the 
medication related problems nomenclature, including 
adverse drug reactions, adverse drug events, and medication 
errors. Within the training session, the pharmacy students 
were then tested on their knowledge regarding MRPs with a 
pre/posttest examination. The results from the assessments 
showed a 66.9% improvement from the pretest to posttest, 
and ultimately indicated the advantages of education with 
regards to identifying MRPs.  
While some information exists on medication safety 
education in the didactic curricula, little information exists on 
this type of education in the APPE setting. ASHP states that 
“students often enter experiential rotations with limited 
knowledge about medication error prevention, a safety 
culture, or how to apply generally accepted safe practices”.12 
In their policy positions on education and training, ASHP 
notes that medication safety is so important that students 
should receive education on the topic throughout didactic 
courses as well as experiential education, and encourages 
experiential preceptors to help students identify potential 
areas for improvement within the system.12 
The purpose of this study was to assess fourth year pharmacy 
students on their knowledge of and ability to properly 
identify and categorize medication related problems (MRP) 
during their Advanced Pharmacy Practice Experience (APPE) 
in the ambulatory care setting, and to assess the efficacy of a 
written resource designed to educate and train users on 
identification and documentation of MRP’s and used for this 
purpose with participating students on their ambulatory care 
APPE.  
Methods 
To effectively evaluate their baseline knowledge on MRP’s, 
fourth year pharmacy students were given an identical 
pretest and posttest while on their ambulatory care rotation 
at the Jefferson County Department of Health in Birmingham, 
Alabama. The test was created by the primary investigator, 
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who also served as one of the two faculty experiential 
preceptors for the site. The tests consisted of ten multiple-
choice questions, which covered three key components with 
regards to patient and medication safety and were based off 
of the training document that the students received upon 
completion of the pretest. Firstly, the survey was designed to 
challenge the students’ ability to distinguish between 
potential adverse drug events (pADE), adverse drug events 
(ADE), and medication errors (ME). Secondly, the questions 
tested the students’ ability to categorize medication related 
problems (MRPs), determining whether or not an ADE or ME 
occurred, and rating the severity of patient harm according 
the NCC MERP Index for Categorizing Medication Errors. 
Finally, the survey questions tested the students’ ability to 
categorize the MRP according the suspected root problem of 
the patient case.  
The pretest survey was emailed to students at the start of 
their ambulatory care APPE in the form of a Google Docs link, 
and the results were recorded for the preceptors to evaluate. 
After completion of the pretest, students received a written 
copy of the Medication Therapy Intervention & Safety 
Documentation Program training manual via email and were 
instructed to read the contents in its entirety during the first 
week of their APPE.  The Medication Therapy Intervention & 
Safety Documentation Program is the system utilized to 
document MRP’s at the Jefferson County Department of 
Health by pharmacy preceptors, residents, and students on 
their APPE, and was developed by Dr. Steve Chen. This 
documentation system has also been used by the Health 
Resources and Services Administration (HRSA) Patient Safety 
and Clinical Pharmacy Services Collaborative (PSPC) as the 
primary documentation tool for medication-related problems 
including medication safety issues, and both the form and the 
training manual are available electronically.18,19  
The manual itself sought to provide background information 
related to identifying, categorizing, and reporting medication-
related problems in the realm of pharmacy practice. In 
addition, the manual also offered insight in defining pADEs, 
ADEs, and ME, and explained how to properly input this data 
into a program. After reading the training manual, the 
students were emailed the link to the Google Docs posttest 
survey (identical to the pretest survey) and instructed to 
complete the questions with their newfound knowledge and 
training with regards to medication and patient safety. 
Results from the posttest survey were then collected and 
reviewed by the faculty preceptors to ensure completion. 
Students received credit for completing the assignment as 
part of their grade for the APPE, but the credit was not 
performance based.  
Results  
There was a 100% response rate from the 18 students, who 
completed both the pretest and posttest multiple-choice 
question survey. Data analysis was assisted by Minitab, 
release 162.2.2 software. A paired t-test with a repeated 
measures design was performed to assess for increases in the 
students’ knowledge regarding patient safety and for 
classifying MRPs as measured by the identical pretest and 
posttest instrument. Table 1 depicts the results from each 
question, along with the total score for the pretest and 
posttest instrument. Out of a perfect score of 10, the mean 
pretest was found to be 6.333 (63.33%). In addition, the 
standard deviation and standard error of the mean with 
pretest was 1.320 and 0.311 respectively. The mean score of 
the posttest was found to be 6.278 (62.78%), while the 
standard deviation and standard error of the mean was 1.320 
and 0.311 respectively. The mean difference between the 
pretest and posttest was not found to be statistically 
significant. However, there was a statistical significance 
observed in question 9 of the survey, which tested the 
student’s knowledge on classifying MRPs using a modified 
NCC MERP Index for Categorizing Medication Errors guide. A 
decline in student knowledge was observed in this question 
from pretest to posttest (95% CI for mean difference: (0.038, 
0.629), p-value=0.029). 
Discussion        
Initial results from the pretest indicate a limited knowledge 
base on MRP’s for students from the study institution, and 
have prompted discussion amongst faculty on where in the 
curriculum additional content on medication safety can be 
included. While extrapolation of data for the pretest results 
will be limited due to it being content-specific for a single 
school of pharmacy, it does indicate a potential need for all 
institutions to assess student knowledge and performance in 
this area to ensure that they are receiving a sufficient amount 
of exposure to content on medication safety in the didactic 
curriculum that they can apply in the experiential setting. 
While students’ answers improved on five of the ten 
questions, the data analysis did not indicate an increase in 
overall student knowledge with regards to patient and 
medication safety with the use of a pre and post intervention 
method. More importantly, the total mean scores from the 
pretest to the posttest actually declined with the 
incorporation of the patient safety and training orientation 
document provided before the posttest. This result may 
potentially indicate that the written training document was 
ineffective in teaching students how to explain, categorize, 
and distinguish between MRPs. The lack of improvement in 
student knowledge may demonstrate that an educational 
method utilizing more of an active learning approach may be 
more effective in allowing students to apply and retain 
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content related to medication safety, particularly in the 
experiential setting.   
 
One limitation observed in this study was the small sample 
size (N=18), which increased the difficulty in detecting small 
changes in pretest and posttest scores. A larger sample size 
could potentially be obtained by incorporating students from 
a variety of ambulatory care APPE practice sites, as a single 
site has a limited capacity for students over the course of a 
year. Additionally, there would be benefit to comparing the 
written educational method to an active learning method 
between separate student groups- however, this again would 
require a larger sample size and would need coordination 
between preceptors at multiple practice sites. 
 
One way that the results have changed the medication safety 
training that students receive at the study practice site is that 
rather than being trained only by using the written 
document, students now also participate in a group 
discussion regarding MRP’s identified in the previous month 
at the practice. Students have the ability to observe how the 
MRP’s were identified, classified, and categorized, and to ask 
questions during the discussion for clarification or additional 
information. While the efficacy of this method has not yet 
been formally evaluated, anecdotal observation of the two 
preceptors indicates that students have shown an increased 
interest and engagement in the documentation of MRP’s 
following the group discussion. 
 
Conclusion 
Education in the didactic pharmacy curriculum on medication 
safety is encouraged by many national organizations, but may 
be inadequate at some institutions. Furthermore, there is 
little published literature regarding education on medication 
safety in the APPE setting. Based on the results of the pre-
test, students at our institution enter their APPE year with 
limited baseline knowledge of medication safety within the 
ambulatory care setting. Additionally, the results of the post-
test within this sample of students suggest that utilization of 
a written document on MRP’s is not an effective educational 
method. Rather, training students on medication safety 
within the experiential setting may be made more effective 
with a hands-on, active learning approach that overcomes the 
limitations of other passive forms of learning. Regardless, 
great care must be taken to ensure that the key 
fundamentals of medication use and patient safety are well 
understood by fourth year pharmacy students to improve 
their expertise and clinical knowledge during the Advanced 
Pharmacy Practice Experience (APPE) and for use as future 
practicing pharmacists.       
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Table 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
   
PRETEST     MEAN(SD) 
 
POSTTEST MEAN (SD) 
 
Q1 
 
0.889 (0.323) 
 
0.778 (0.428) 
 
 
Q2 
 
0.8333 (0.3835) 
 
0.9444(0.2357) 
 
 
Q3 
 
0.8889 (0.3234) 
 
1.0000 (0.000) 
 
 
Q4 
 
0.222 (0.428) 
 
0.111 (0.323) 
 
 
Q5 
 
0.333 (0.485) 
 
0.278 (0.461) 
 
 
Q6 
 
0.9444 (0.2357) 
 
1.000 (0.0000) 
 
 
Q7 
 
0.8333 (0.3835) 
 
0.9444(0.2357) 
 
 
Q8 
 
0.278 (0.461) 
 
0.444 (0.511) 
 
 
Q9a 
 
0.556 (0.511) 
 
0.222 (0.428) 
 
 
Q10 
 
0.556 (0.511) 
 
0.000 (0.594) 
 
TOTAL SCORE PRETESTb 6.333 (1.283) 
    
TOTAL SCORE POSTTESTb 
   
6.278 (1.320) 
 
         
                  
a. 95% CI for mean difference: (0.038, 0.629), p-value = 0.029 
   
b. 95% CI for mean difference: (-0.735, 0.846), p-value = 0.884 
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Appendix 1. Patient Safety Pretest/Posttest Survey 
 
1. Which of the following would best be described as an event which caused harm by a drug or the inappropriate use of a drug?    
A. Potential Adverse Drug Event (pADE)  
B. Adverse Drug Event (ADE)  
C. Adverse Drug Reaction (ADR)  
D. Medication Error (ME)  
 
2. Which of the following would best be described as circumstances that could result in harm by the use of a drug but did not harm 
or reach the patient?    
A. Potential Adverse Drug Event (pADE)  
B. Adverse Drug Event (ADE)  
C. Adverse Drug Reaction (ADR)  
D. Medication Error (ME)  
 
3. Which of the following would best be described as harm caused by a drug at a normal dose and during normal use?     
A. Potential Adverse Drug Event (pADE)  
B. Adverse Drug Event (ADE)  
C. Adverse Drug Reaction (ADR)  
D. Medication Error (ME)  
 
4. Newly diagnosed obese adult Type 2 DM patient NOT receiving metformin. Classify the medication-related problem.  
A. Appropriateness/Effectiveness : Untreated medical problem  
B. Safety: Incomplete / improper directions  
C. Appropriateness/Effectiveness : Treatment not optimal based on current evidence / guidelines  
D. Safety: No indication for medication prescribed  
 
5. Medical record indicates that patient should be taking metformin 500mg BID, but pt is taking metformin 500mg daily and A1C 
consistently below 7%.   Classify the medication-related problem.  
A. Appropriateness/Effectiveness : Drug dosing not adequate for treatment goals  
B. Safety: Drug dosing excessive for treatment goals  
C. Non-adherence/Patient Variable: Medication underuse / poor adherence  
D. Miscellaneous: Other  
 
6. Diabetes patient commonly forgets to take dose of Byetta before dinner and A1C is 7.3%   Classify the medication-related problem 
.  
A. Appropriateness/Effectiveness : Treatment not optimal based on current evidence / guidelines  
B. Safety: No indication for medication prescribed  
C. Non-adherence/Patient Variable: Medication underuse / poor adherence  
D. Safety: Adverse drug reaction (ADR)  
 
7. Patient prescribed a penicillin antibiotic even though listed penicillin allergy; patient bought and took medication and developed 
hives. Benadryl required to resolve hives.   Classify the medication related problem according to the modified NCC MERP 
Classification Index.  
A. Classification C: Med error/event reached patient, but no harm  
B. Classification D: Med error/event reached patient, monitoring or intervention required to confirm no harm  
C. Classification E: Event occurred, resulting in temporary harm and requiring intervention  
D. Classification F: Event occurred, resulting in temporary harm and requiring hospitalization  
 
8. Patient discontinues blood pressure medication due to cost. Blood pressure becomes elevated; however the patient is 
asymptomatic and all labs are within normal limits.   Classify the medication related problem according to the modified NCC MERP 
Classification Index.  
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A. Classification A: No med error / event, but potential for ADE identified  
B. Classification B: Med error/event DID NOT reach patient  
C. Classification C: Med error/event reached patient, but no harm  
D. Classification D: Med error/event reached patient, monitoring or intervention required to confirm no harm  
 
9. Patient experiences severe hypoglycemia from insulin secondary to skipping breakfast. Patient required transport to hospital and 
IV dextrose infusion before regaining consciousness.   Classify the medication related problem according to the modified NCC MERP 
Classification Index.   
A. Classification F: Event occurred, resulting in temporary harm and requiring hospitalization  
B. Classification G: Event occurred, resulted in permanent harm / disability  
C. Classification H: Event occurred, life-threatening  
D. Classification I: Event occurred, resulted in death  
 
10. Metformin dispensed with a label reading, “Take by mouth twice daily with dinner”. At next visit, patient asks you if he/she has 
taken his/her metformin correctly. When questioned, patient states he/she took one tablet with breakfast and dinner.   Classify the 
medication related problem according to the modified NCC MERP Classification Index.   
A. Classification A: No med error / event, but potential for ADE identified  
B. Classification B: Med error/event DID NOT reach patient  
C. Classification C: Med error/event reached patient, but no harm  
D. Classification D: Med error/event reached patient, monitoring or intervention required to confirm no harm  
 
Answer Key: 1-B, 2-A, 3-C, 4-A, 5-B, 6-C, 7-C, 8-C, 9-C, 10-C 
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